2 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Unknown 2 |
Follow CoronaVac: new trials by email Literature Review of CoronaVac trials Research Report on CoronaVac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 V-01D-351, CoronaVac - COVID-19 Pandemic | Early Phase 1 | Unknown | Livzon Pharmaceutical Group Inc. | 40 | 2022-08-15 | 2022-10-19 |
| The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001 LYB001, CoronaVac - COVID-19, Vaccine Reaction | Early Phase 1 | Unknown | Guangzhou Patronus Biotech Co., Ltd. | 120 | 2022-05-14 | 2023-07-03 |
COVID-19 (2)
Guangzhou Patronus Biotech Co., Ltd. (1) · Livzon Pharmaceutical Group Inc. (1)
China (2)